Naloxegol Reverses Opioid-Induced Esophageal Dysmotility

Naloxegol appears to reverse opioid-induced esophageal dysmotility in the same way as it does opioid-induced ...

JULY 25, 2021

Managing Opioid-Induced Constipation in Adults With Chronic Noncancer Pain: Clinical and Case-Based Considerations

JUNE 11, 2018

Efficacy of Naloxegol for OIC Not Influenced by Opioid Type, Dose

Naloxegol to treat opioid-induced constipation showed similar efficacy regardless of opioid type or dose, according ...

OCTOBER 4, 2017

FDA Approves Naldemedine for OIC in Adults With Chronic Noncancer Pain

Naldemedine is a peripherally acting mu-opioid antagonist designed to be taken once daily by adults with OIC. The ...

MARCH 24, 2017

Methylnaltrexone for Opioid-Induced Constipation Might Also Improve Overall Survival in Advanced Cancer Patients

Methylnaltrexone influenced cancer progression and prolonged survival in patients with advanced cancer, suggesting ...

JANUARY 6, 2016